Passage BIO, Inc. (PASG) › Free Cash FlowPassage BIO, Inc. (PASG): Free Cash FlowOperating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.-$47.99MYear ended 2024-12-31Period endedFree Cash FlowChange YoYSource filing2024-12-31-$47.99Mn/a2026-03-03, From 2024-01-01Other metrics: R&D ExpenseOperating IncomeDepreciation & AmortizationEBITDANet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingWeighted Average Diluted SharesEPS (Basic)